Sangamo Therapeutics Inc (SGMO)
1.225
-0.14
(-10.58%)
USD |
NASDAQ |
Jan 08, 11:13
Sangamo Therapeutics Enterprise Value: 246.65M for Jan. 7, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pfizer Inc | 210.68B |
| Verastem Inc | 239.71M |
| AIM ImmunoTech Inc | 10.40M |
| Protalix BioTherapeutics Inc | 137.53M |
| Armata Pharmaceuticals Inc | 165.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 10.67M |
| Revenue (Quarterly) | 49.41M |
| Total Expenses (Quarterly) | 38.78M |
| EPS Diluted (Quarterly) | 0.04 |
| Profit Margin (Quarterly) | 21.60% |
| Earnings Yield | -61.22% |
| Normalized Earnings Yield | -59.16 |